Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by bohemian62on Apr 14, 2021 8:10am
183 Views
Post# 32991207

RE:RE:RE:RE:RE:RE:RE:Price target 1,4 CAD from germany

RE:RE:RE:RE:RE:RE:RE:Price target 1,4 CAD from germanyThe continuation of the growth in total sales is clearly noticeable (Figure 4, left). This will generate sales with CAD 6.6 million in Q4 2020 and CAD 8.6 million in Q1 2021 as CAD 10.6 million in Q2 2021 calculated. This results in an increase of around 35% in Q4 compared to Q3 and a continuous increase of a further 30% in Q1 compared to Q4 and 25% in Q2 compared to Q1 2021. In addition, the operating result and EBITDA improve. For Q1 2021 becomes a positive EBITDA at 21,940 CAD and for Q2 2021 at around 188,000 CAD. In the first quarter of Q1 2020 there was no positive change in sales at Datametrex compared to Q4 2019, as DM did not start selling COVID test kits until April 2020

The above is an excerpt from the link :

1g7dinn-210414_DM ESTIM REVENUE PRICE TARGET_english.pdf
<< Previous
Bullboard Posts
Next >>